OnCo
trialsTrial

Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma

A phase 3 trial of Ibandronic acid and Zoledronic acid in Multiple myeloma, run by Hoffmann-La Roche, recorded as terminated on the registry.